MTPConnect public
[search 0]
Download the App!
show episodes
 
In this limited podcast series, we’ve brought together a series of conversations with experts from medical science to finance to help demystify investing in biotech, medtech and digital health (also known as the life sciences). This podcast has been brought to you by Life Sciences WA (Western Australia’s Life Sciences Industry Association) in collaboration with Talking HealthTech. It has been possible with funding support from the West Australian government through the New Industries Fund an ...
  continue reading
 
Loading …
show series
 
Perth- based biotech Argenica Therapeutics is developing therapies to treat stroke and other neurological conditions. A new neuroprotective peptide treatment is now being tested for ischaemic stroke patients presenting to emergency departments at 10 hospitals around Australia and is expected to improve patient outcomes by protecting the brain tissu…
  continue reading
 
Innovators have told us that funding is important but difficult to navigate. The Australian Government is committed to investing billions of dollars into medical research and industry growth, cultivating a culture of translation and improving health for all Australians. So MTPConnect’s Adelaide Intermediary Program kicked off its first SA Insights …
  continue reading
 
MTPConnect’s Clinical Translation and Commercialisation Medtech (CTCM) program held its first annual Symposium in Sydney recently, bringing together all 11 companies from around Australia who are recipients of CTCM funding to develop new medical devices to improve health and wellbeing. In this episode, host Caroline Duell meets some of these Austra…
  continue reading
 
In this episode of the LSWA podcast, host Tracey Wilkinson interviews Fleta Solomon and Michael Winlo, two experts in the field of psychedelic-assisted therapy and medical cannabis. They discuss the potential of these treatments to revolutionise mental health care and provide a more holistic approach to patient care. The conversation begins with a …
  continue reading
 
In this episode of the LSWA podcast, host Tracey Wilkinson sits down with Natalie Barber, the director of Clinical Operations at Chrysalis Advisory, and Professor Peter Richmond from the University of Western Australia. Natalie and Peter discuss their respective roles in the clinical trial space. Peter, a paediatrician, focuses on improving childre…
  continue reading
 
In this episode of the Investor Meets Innovator Podcast, host Peter Birch sits down with Paul Anderson, the Managing Director of Orthocell. With over 25 years of experience in the medical space and a background in device development and regenerative medicine, Paul shares his insights on the life sciences industry and the journey of bringing innovat…
  continue reading
 
The GSK Australia Graduate Researcher Program (GRP) is a 12-month work placement program for PhD graduates supported by MTPConnect's Researcher Exchange and Development within Industry (REDI) initiative showcasing opportunities in the pharmaceutical industry by providing hands-on experience for postdoctoral biomedical/science researchers. Since 202…
  continue reading
 
The GSK Australia Graduate Researcher Program (GRP) is a 12-month work placement program for PhD graduates supported by MTPConnect's Researcher Exchange and Development within Industry (REDI) initiative showcasing opportunities in the pharmaceutical industry by providing hands-on experience for postdoctoral biomedical/science researchers. Since 202…
  continue reading
 
In this episode of LSWA Investor Meets Innovator, Host Tracey Wilkinson talks with Simon Handford and Angela Fonceca about the challenges and complexities of tech transfer offices and taking research to commercialisation. They discuss the challenges of taking an innovation from academia and industry, the slow pace of negotiations, issues with fundi…
  continue reading
 
In this episode of the Investor Meets Innovator Podcast, host Peter Birch is joined by Ian Brown, Executive Chairman, and Intan Oldakowska, Chief Scientific Officer, of Rex Ortho. They discuss the journey of Rex Ortho, a platform technology company focused on orthopaedic fixations, particularly in proximal femoral fractures. Intan shares the backgr…
  continue reading
 
As thousands in the medical technology sector headed to Anaheim, California for The MedTech 2023 Conference, MTPConnect was making sure that the 20 companies and organisations joining the Australian delegation were given opportunities to showcase their capabilities and make valuable US and international connections. In this podcast special from Los…
  continue reading
 
In this episode of the Investor Meets Innovator Podcast, host Peter Birch speaks with Arjun Balaji, an analyst with a clinical background at Tenmile, a venture capital firm in Perth, Western Australia. Arjun shares his background in medicine and his journey into the world of biotech startups before transitioning to investing. In this episode Arjun …
  continue reading
 
In this episode of the Investor Meets Innovator Podcast, host Peter Birch sits down with Dr Melissa McBurnie, Partner and Head of Impact at Brandon Capital. You will hear about how Brandon Capital approaches investing with impact in the life sciences and get some insights into the processes that they use when making an investment in this space. You…
  continue reading
 
Dubbed the superbug pandemic, antimicrobial resistance (AMR) has been recognised by the World Health Organization as one of the top 10 public health threats facing humanity. Effective antibiotics underpin modern medicine and yet, it takes just two to three years for new antimicrobial medicines to become ineffective against superbugs. Worryingly, th…
  continue reading
 
Many well-known Australian medical innovations have been developed by visionary clinicians – doctors, nurses and allied health professionals – including the cochlear implant and spray on skin. In this special series we continue to explore how medical entrepreneurship can transform healthcare and meet Associate Professor Fiona Brownfoot, a specialis…
  continue reading
 
Many well-known Australian medical innovations have been developed by visionary clinicians – doctors, nurses and allied health professionals – including the cochlear implant and spray on skin. In part 1 of this double episode, we explore medical entrepreneurship in Australia with Dr Brandon Carp, a Melbourne-based doctor who changed up his medical …
  continue reading
 
As Australia’s life sciences industry accelerator, MTPConnect’s is backing Australian medical devices of the future through the BioMedTech Horizons Program. It’s a $45 million initiative of the Medical Research Future Fund to bring life-saving medical products from an idea to patients. It’s about nurturing medtech companies through the first valley…
  continue reading
 
As Australia’s life sciences industry accelerator, MTPConnect’s is backing Australian medical devices of the future through the BioMedTech Horizons Program. It’s a $45 million initiative of the Medical Research Future Fund to bring life-saving medical products from an idea to patients. It’s about nurturing medtech companies through the first valley…
  continue reading
 
MTPConnect’s REDI Fellowships are improving engagement between researchers and industry and providing fellows with real-world innovation experiences within commercial industry settings. The idea of connecting researchers with industry is critical for the growth of Australia’s medical products sector and so far, 49 Fellows have been selected for ind…
  continue reading
 
After the international BIO 2023 convention wrapped up with Team Australia, MTPConnect took a tour of global biopharmaceutical company Sanofi’s mRNA Centre of Excellence located in Greater Boston and learnt more about the company’s plans for the Translational Science Hub being set up in Queensland in partnership with the Queensland Government, Grif…
  continue reading
 
We take you to MTPConnect’s inaugural seminar on 'Australian Women in Life Sciences Leadership - a Global Perspective' held during BIO 2023 in Boston. Founders, CEOs, board executives and managers gathered to discuss the opportunities and challenges faced by women in the biotech industry in a changing global market. The seminar, supported by Sanofi…
  continue reading
 
Back in June, MTPConnect joined the Australian delegation at BIO in Boston and organised several activities to showcase Australia’s fast-growing life sciences sector to the international biotech industry. With a powerful #TeamAustralia focus and a 430-strong delegation from Australia, BIO2023 was literally the biggest and best to date with over 20,…
  continue reading
 
Vexev founders, Dr John Carroll and Dr Eamonn Colley met in Sydney as PhD students interested in fluid dynamics. They have turned their talents to investigate blood flows to try and predict vascular disease. They have created an ultrasound-powered imaging robot and software platform — to automatically take fast and consistent 3D scans, to superchar…
  continue reading
 
ARIA Research is a Sydney-based start-up developing technologies delivering a sense of vision via sound (echolocation) to people who are blind or have low vision. The company’s defining advantage has been its diverse and inclusive team, which incorporates employees and end users living with blindness into every aspect of the project and organisatio…
  continue reading
 
Tens of thousands of central venous catheters designed for adult bodies are inserted into the delicate veins of newborns in Australian intensive care settings every year for life-saving care. But positioning the catheter tip can be challenging and if not done correctly, can lead to dangerous complications for children who are already critically ill…
  continue reading
 
ANDHealth specialises in the acceleration of commercialisation of evidence-based digital health technologies through targeted programs and expert support. Their ANDHealth + Program funded by the Australian Government’s Medical Research Future Fund has opened for applications. ANDHealth Co-founder and Chief Product Officer Grace Lethlean explains ho…
  continue reading
 
In July 2022, Defence launched the 'Safeguarding Australia through Biotechnology Response and Engagement' (SABRE) Alliance, to bring together biotech capabilities from Australia’s universities, research institutes, SMEs and manufacturers to connect them with the needs of the Defence and national security sectors. MTPConnect has played a role in est…
  continue reading
 
BellaSeno is a clinical-stage medical device company born in Queensland in 2015 and now expanded to Liepzig in Germany. They are developing a next generation fully resorbable breast implant for soft tissue reconstruction, which recently started clinical trials in Australia. We connect with BellaSeno’s Co-Founder & Chief Executive Officer Dr Mohit C…
  continue reading
 
To mark our 150th episode, we are delighted to introduce MTPConnect’s newly appointed Chair, the Honorable Jaala Pulford. A passionate advocate for the medical technology, biotech and pharmaceutical sector, Jaala has a long and distinguished career in government including Minister for Innovation, Medical Research and the Digital Economy. Jaala chat…
  continue reading
 
The Targeted Translation Research Accelerator (TTRA) program, a Medical Research Future Fund initiative delivered by MTPConnect, launched Round 3 of its Research Projects funding opportunity on 30 January 2023 to support diabetes and cardiovascular disease projects that address the unmet health and medical needs of Aboriginal and Torres Strait Isla…
  continue reading
 
It’s three years ago this month that COVID-19 was declared a pandemic by the World Health Organisation. We’ve seen nearly 800 million confirmed cases around the world and nearly 7 million deaths… and there are signs that another wave is underway in Australia as we head into the colder months. But imagine those numbers if we didn’t have the vaccines…
  continue reading
 
Our Targeted Translation Research Accelerator (TTRA) program, a Medical Research Future Fund initiative delivered by MTPConnect, launched Round 3 of its Research Projects funding opportunity in January 2023 to support diabetes and cardiovascular disease projects that address the unmet health and medical needs of Aboriginal and Torres Strait Islande…
  continue reading
 
We talk to Sydney-based eye surgeon Dr Sarah Crowe, Founder and Director of 4eyesVision who has invented the 4eyesVision Kit to correct refractive error, the leading cause of blindness in the developing world and provide affordable glasses on the spot for people in remote and developing communities. Dr Crowe shares her clinician entrepreneur story …
  continue reading
 
MTPConnect’s Targeted Translation Research Accelerator (TTRA) program has opened a new funding round to support diabetes and cardiovascular disease research projects that address the unmet health and medical needs of Aboriginal and Torres Strait Islander peoples in rural, remote, regional, and urban centres. To develop this Indigenous-specific roun…
  continue reading
 
For this episode we tap into an international perspective on the digital health sector and the business of healthcare. Lisa Suennen is a US-based entrepreneur and industry advisor. After thirty years in healthcare and seeing little progress in efficiency and optimisation of care, she moved into the digital health space, working as a venture capital…
  continue reading
 
Australian company Minomic has developed the MiCheck Prostate blood test that uses an algorithm, together with other biomarkers, to estimate the risk of a patient having aggressive prostate cancer. The diagnostic overcomes the low accuracy of conventional screening tests to reduce unnecessary intervention such as painful biopsies and improve overal…
  continue reading
 
In this episode of the Life Sciences WA Podcast, Dr Tara Speranza discusses her work as a healthcare and biotech analyst at Bell Potter Securities. Dr Speranza is part of a group of three analysts who cover the healthcare and biotech sector in Australia, focusing on companies listed on the ASX. She has a background in molecular biology and endocrin…
  continue reading
 
Investment in life sciences in Western Australia is an area of great interest, as shown by the recent Life Sciences WA podcast episode featuring guests Greg Riebe and Steve Elias. Riebe is a company director and angel investor with decades of experience in commercialising emerging technologies and is currently a Commercialisation Facilitator for th…
  continue reading
 
This episode features conversations with Paul Watt, Co-Founder and Executive Chair of Avicena Systems and Liddy McCall, Director of Yuuwa Ventures Investment in life sciences in Western Australia has grown significantly in recent years. This growth has been driven by several factors, including the state's strong research and development infrastruct…
  continue reading
 
In this episode of the Life Sciences WA Podcast, Dr Bi Mian discusses his work with the Australian Medical Angels, a medical syndicate that focuses on investing in HealthTech start-ups in Australia. Dr Mian, who is a medical doctor and runs a multi-specialist medical centre in regional New South Wales, founded the group with his co-founder Dr Amand…
  continue reading
 
In this podcast episode of the Life Sciences WA Podcast, the guest was Bronwyn LeGrice, CEO of ANDHealth. The focus of the discussion was on investing and commercialising digital health. LeGrice introduced herself and discussed her background, which included seven years in venture capital and over 20 years in the commercialisation of medical techno…
  continue reading
 
Dr Alma Fulurija Dr Alma Fulurija is the Head of the Strep A Vaccines team at Telephone Kids Institute. In this interview, she discussed the process of vaccine development, which is a long, expensive, and high-risk process, but has the potential for high rewards if successful. The Covid-19 pandemic has shown that vaccine development can be done fas…
  continue reading
 
Glenn Butcher is the CEO of FundWA, a venture capital firm focused on investing in technology-enabled innovation businesses in Western Australia. In this interview, he discussed the potential for growth and success in this area, highlighting the state's strong track record in life sciences research and the potential for commercialising this researc…
  continue reading
 
MTPConnect’s Targeted Translation Research Accelerator (TTRA) program will open Round 3 of its Research Projects funding opportunity in early 2023 to support diabetes and cardiovascular disease projects that address the unmet health and medical needs of Aboriginal and Torres Strait Islander peoples in rural, remote, regional, and urban centres. In …
  continue reading
 
It’s World Antimicrobial Awareness Week and this year’s theme is “Preventing Antimicrobial Resistance Together”. We chat to Bugworks, a clinical stage pharmaceutical company, headquartered in the US, with subsidiaries in India and Australia, currently developing novel antibacterials and immunotherapies. Bugworks’ Co-founder and Chief Executive Offi…
  continue reading
 
MTPConnect hits The MedTech Conference in Boston, USA, leading a delegation of 18 Australian companies to showcase Australia’s outstanding innovative medical technologies and capabilities to the world’s largest medtech market. With the creation of the unmissable Australian Pavilion exhibit and a top-level visit program of keynotes and networking ev…
  continue reading
 
MTPConnect hits The MedTech Conference in Boston, USA, leading a delegation of 18 Australian companies to showcase Australia’s outstanding innovative medical technologies and capabilities to the world’s largest medtech market. With the creation of the unmissable Australian Pavilion exhibit and a top-level visit program of keynotes and networking ev…
  continue reading
 
CSIRO’s year-round Kick-Start program has helped over 200 early-stage start-ups and small businesses pursue R&D activities by providing access to CSIRO research and capability. This includes help with articulating a company’s research question, connecting businesses with relevant CSIRO researchers and fifty per cent matched funding support to impro…
  continue reading
 
Inventia Skin is a Sydney-based start-up on a mission to revolutionise wound repair by developing Ligō, a skin printing robot. It delivers rapid and precise regenerative cellular therapy products directly onto a wound and could help to treat difficult to heal skin burns. A number of partners - high profile scientists and physicians - are lending th…
  continue reading
 
Back in May 2019, MTPConnect launched the Biomedical Translation Bridge (BTB) program, a $22.3 million initiative of the Medical Research Future Fund, supporting the translation of new therapies, technologies and medical devices through to the proof-of-concept stage. In a first for Australia, it did that by pairing funded projects with industry men…
  continue reading
 
Loading …

Quick Reference Guide